Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
About this item
Full title
Author / Creator
Visca, Dina , Tsipouri, Vicky , Mori, Letizia , Firouzi, Ashi , Fleming, Sharon , Farquhar, Morag , Leung, Elizabeth , Maher, Toby M , Cullinan, Paul , Hopkinson, Nick , Wells, Athol U , Banya, Winston , Whitty, Jennifer A , Adamali, Huzaifa , Spencer, Lisa G , Sestini, Piersante and Renzoni, Elisabetta A
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Fibrotic interstitial lung diseases (ILDs) are chronic and often progressive conditions resulting in substantial morbidity and mortality. Shortness of breath, a symptom often linked to oxygen desaturation on exertion, is tightly linked to worsening quality of life in these patients. Although ambulatory oxygen is used empirically in their treatment,...
Alternative Titles
Full title
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1e0847b9abb54af8a13a2c50967bead6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e0847b9abb54af8a13a2c50967bead6
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-017-1912-9
